Monitoring a high-cost drug in critical care units

Ítems similars

• Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients
  per: Boyle, A, et al.
  Publicat: (2010)
• Levosimendan: experience of an adult ICU
  per: Lippett, S, et al.
  Publicat: (2006)
• Peaks and troughs: variations in the availability of therapeutic drug monitoring in critical care units across London
  per: Grailey, KE, et al.
  Publicat: (2015)
• H2 blockers in the intensive care unit: ignoring the evidence? Telephone survey.
  per: Wyncoll, D. L., et al.
  Publicat: (1997)
• Adverse drug events in the critical care unit
  per: Seynaeve, S, et al.
  Publicat: (2010)